Chargement en cours...

Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar

BACKGROUND: Etanercept is prescribed for the rapid and effective treatment of chronic immune-mediated inflammatory disorders. Due to the expiration of etanercept patents and worldwide demand for comparable and more affordable substitutes, several biosimilars of etanercept have been approved in diffe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Iran J Biotechnol
Auteurs principaux: Fazel, Ramin, Mahboudi, Fereidoun, Seyedjafari, Ehsan, Sardari, Soroush, Vaziri, Behrouz
Format: Artigo
Langue:Inglês
Publié: National Institute of Genetic Engineering and Biotechnology 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357702/
https://ncbi.nlm.nih.gov/pubmed/32671128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.30498/IJB.2019.99581
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!